ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 70 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $40,000 | -11.1% | 18,891 | -3.4% | 0.00% | – |
| Q2 2018 | $45,000 | -74.1% | 19,555 | -64.2% | 0.00% | – |
| Q1 2018 | $174,000 | -4.9% | 54,578 | +22.4% | 0.00% | – |
| Q4 2017 | $183,000 | +20.4% | 44,578 | +32.7% | 0.00% | – |
| Q3 2017 | $152,000 | -1.3% | 33,587 | -27.0% | 0.00% | – |
| Q2 2017 | $154,000 | +41.3% | 45,997 | +289.8% | 0.00% | – |
| Q1 2017 | $109,000 | -60.4% | 11,800 | -67.0% | 0.00% | – |
| Q4 2016 | $275,000 | +88.4% | 35,706 | +179.5% | 0.00% | – |
| Q3 2016 | $146,000 | +15.0% | 12,773 | +126.2% | 0.00% | – |
| Q4 2015 | $127,000 | -51.9% | 5,648 | -36.9% | 0.00% | – |
| Q4 2013 | $264,000 | – | 8,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 4,108,815 | $4,273,000 | 0.48% |
| Birchview Capital, LP | 372,557 | $387,000 | 0.24% |
| Perceptive Advisors | 1,719,111 | $1,787,000 | 0.05% |
| Fondren Management LP | 25,136 | $26,000 | 0.02% |
| Cannell & Co. | 281,983 | $293,000 | 0.01% |
| APPLETON PARTNERS INC/MA | 66,206 | $69,000 | 0.01% |
| Quinn Opportunity Partners LLC | 66,162 | $69,000 | 0.01% |
| NJ State Employees Deferred Compensation Plan | 38,000 | $40,000 | 0.01% |
| Candriam S.C.A. | 380,000 | $395,000 | 0.01% |
| PRIMECAP MANAGEMENT CO/CA/ | 5,451,400 | $5,669,000 | 0.00% |